| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $238K | +34.8% |
| SG&A Expense | $1.5M | +76.2% |
| Operating Income | -$2.6M | -23.3% |
| Interest Expense | $154K | +0.0% |
| Pre-tax Income | -$3.0M | +21.1% |
| Net Income | -$3.0M | +21.1% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -33.9% |
| Inventory | $7K | +4.6% |
| Current Assets | $2.6M | -35.4% |
| Total Assets | $3.2M | -29.3% |
| Current Liabilities | $8.9M | +10.1% |
| Total Liabilities | $8.9M | +10.5% |
| Stockholders' Equity | -$5.7M | -62.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +34.1% |
| Capital Expenditures | $6K | +27.4% |
| Investing Cash Flow | -$6K | -27.4% |
| Financing Cash Flow | -$60K | -101.8% |
| Free Cash Flow | -$1.3M | +33.9% |